1-17 of 17
Antonietta Pia Falcone, MD
Close
Sort by
Journal Articles

First Interim Report of the Italian Multicentric Phase-III Randomized Study to Optimize TKIs Multiple Approaches - (OPTkIMA) in Elderly Patients (older than 60 years) with Ph+ Chronic Myeloid Leukemia (CML) and MR3.0/ MR4.0 Stable Molecular Response

Michele Malagola, MD, Fabio Efficace, PhD, Nicola Polverelli, MD, Elisabetta Abruzzese, Alessandra Iurlo, Cristina Bucelli, MD, Fabio Stagno, Massimiliano Bonifacio, Mariella D'adda, MD, Monia Lunghi, Monica Crugnola, MD, Francesca Lunghi, Fausto Castagnetti, Gianantonio Rosti, Ferrari Maria Luisa, Micaela Bergamaschi, MD, Gianni Binotto, MD, Rosaria Sancetta, MD, Maria Rosaria Coppi, Valentina Giai, Giovanna Rege Cambrin, MD, Atelda Romano, Mario Tiribelli, Sabina Russo, Lara Aprile, Antonietta Pia Falcone, MD, Serena Rupoli, MD, Antonella Russo Rossi, MD, Emilio Usala, MD, Bruno Martino, MD, Lisa Gandolfi, Simona Bernardi, PhD, Camilla Zanaglio, PhD, Mirko Farina, MD, Michele Baccarani, MD, Domenico Russo, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4251.
https://doi.org/10.1182/blood-2018-99-110250
Published: 2018
Journal Articles

First-Line Treatment with Nilotinib in Chronic Myeloid Leukemia Patients in Real-Life: Results of the Observational Study Gimema CML0912

Gabriele Gugliotta, MD PhD, Fausto Castagnetti, MD, Francesca Lunghi, MD, Serena Rupoli, MD, Elisabetta Abruzzese, MD, Massimo Breccia, MD PhD, Alessandra Iurlo, MD PhD, Bruno Martino, Patrizia Pregno, MD, Mario Tiribelli, MD, Giovanna Rege Cambrin, Giuseppe Tagariello, Laura Nocilli, Antonietta Pia Falcone, MD, Debora Luzi, Monica Crugnola, MD, Sara Barulli, MD, Massimiliano Bonifacio, MD, Sabina Russo, Delia Noli, MD, Simona Soverini, PhD, Robin Foà, MD, Michele Cavo, MD, Giovanni Martinelli, MD, Fabrizio Pane, MD, Giuseppe Saglio, MD PhD, Michele Baccarani, MD, Gianantonio Rosti, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5253.
https://doi.org/10.1182/blood.V130.Suppl_1.5253.5253
Published: 2017
Journal Articles

Doublet Vs Triplet Lenalidomide-Containing Regimens in Newly Diagnosed Myeloma Patients, Younger or Older Than 75 Years: Subgroup Analysis of a Phase III Study

Valeria Magarotto, MD, Sara Bringhen, MD, Pellegrino Musto, MD, Massimo Offidani, MD, Anna Marina Liberati, MD, Ludek Pour, MD, Giulia Benevolo, MD, Mariella Genuardi, MD, Caterina Musolino, Antonio Ledda, MD, Daniela Oddolo, PhD, Lorenzo De Paoli, MD, Francesca Patriarca, MD, Antonietta Pia Falcone, MD, Isola Caratozzolo, Renato Zambello, MD, Maide Cavalli, MD, Silvia Gentili, MD, Roman Hajek, Mario Boccadoro, MD, Antonio Palumbo, MD
Journal: Blood
Blood (2014) 124 (21): 2110.
https://doi.org/10.1182/blood.V124.21.2110.2110
Published: 2014
Journal Articles

Impact of Autologous Transplantation Vs. Chemotherapy Plus Lenalidomide in Newly Diagnosed Myeloma According to Patient Prognosis: Results of a Pooled Analysis of 2 Phase III Trials

Francesca Gay, MD, Chiara Cerrato, MD, Roman Hajek, Francesco Di Raimondo, MD, Tommaso Caravita, MD, Antonietta Pia Falcone, MD, Francesca Patriarca, MD, Stefano Pulini, Paola Finsinger, MD, Giovannino Ciccone, Paolo Corradini, MD, Agostina Siniscalchi, MD, Francesca Donato, Dina Ben Yehuda, Massimo Offidani, MD, Jiri Minarik, MD PhD, Roberto Ria, MD, Federica Cavallo, MD, Lucio Catalano, MD, Maide Cavalli, MD, Ludek Pour, Doc, MD PhD, Maria Teresa Petrucci, MD, Izhar Hardan, MD, Mario Boccadoro, MD, Andrew Spencer, MD, Antonio Palumbo, MD
Journal: Blood
Blood (2014) 124 (21): 198.
https://doi.org/10.1182/blood.V124.21.198.198
Published: 2014
Journal Articles

Long-Term Molecular Results Of The Gimema VEL-03-096 Trial: Molecular Remission Achievement and Loss Are Major Outcome Predictors

Simone Ferrero, Marco Ladetto, Daniela Drandi, Federica Cavallo, Elisa Genuardi, Marina Urbano, Guglielmo Guarona, Vincenzo Callea, Clotilde Cangialosi, Tommaso Caravita, MD, Claudia Crippa, MD, Luca De Rosa, Antonietta Pia Falcone, MD, Mariella Grasso, Tommasina Guglielmelli, Anna Marina Liberati, Francesco Pisani, Patrizia Pregno, Fausto Rossini, MD, Stefania Oliva, Alberto Rocci, Roberto Passera, Mario Boccadoro, MD, Antonio Palumbo, MD
Journal: Blood
Blood (2013) 122 (21): 2077.
https://doi.org/10.1182/blood.V122.21.2077.2077
Published: 2013
Journal Articles

Persistent Improvement In Clinical Outcomes With Bortezomib-Thalidomide-Dexamethasone Vs Thalidomide-Dexamethasone Incorporated Into Double Autologous Transplantation For Multiple Myeloma: An Updated Analysis Of Phase 3 Gimema-MMY-3006 Study

Michele Cavo, MD, Monica Galli, MD, Annalisa Pezzi, Statistics, Francesco Di Raimondo, MD, Claudia Crippa, MD, Massimo Offidani, MD, Paola Tacchetti, MD, Vittorio Montefusco, MD, Franco Narni, MD, Antonio Spadano, MD, Norbert Pescosta, MD, Elena Zamagni, MD, Barbara Gamberi, MD, Tommaso Caravita, MD, Antonietta Pia Falcone, MD, Chiara Nozzoli, MD, Renato Zambello, MD, Anna Furlan, MD, Annamaria Brioli, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2013) 122 (21): 2090.
https://doi.org/10.1182/blood.V122.21.2090.2090
Published: 2013
Journal Articles

Minimal Residual Disease Monitoring During Maintenance In Multiple Myeloma Patients

Alberto Rocci, Manuela Gambella, Paola Omedè, PhD, Daniela Drandi, Francesca Gay, Francesca Patriarca, MD, Federica Cavallo, Maria Teresa Petrucci, MD, Caravita Tommaso, Giulia Benevolo, Norbert Pescosta, MD, Stefania Oliva, Massimo Offidani, Vittorio Montefusco, Anna Marina Liberati, Antonietta Pia Falcone, MD, Stelvio Ballanti, Tonino Spadano, MD, Tommasina Guglielmelli, Pellegrino Musto, MD, Renato Zambello, MD, Francesco Di Raimondo, MD, Marco Ladetto, Mario Boccadoro, MD, Antonio Palumbo, MD
Journal: Blood
Blood (2013) 122 (21): 3126.
https://doi.org/10.1182/blood.V122.21.3126.3126
Published: 2013
Journal Articles

A Randomized Phase 3 Trial Of Melphalan-Lenalidomide-Prednisone (MPR) Or Cyclophosphamide-Prednisone-Lenalidomide (CPR) Vs Lenalidomide Plus Dexamethsone (Rd) In Elderly Newly Diagnosed Multiple Myeloma Patients

Antonio Palumbo, MD, Valeria Magarotto, Sara Bringhen, MD, Massimo Offidani, MD, Giuseppe Pietrantuono, MD, Anna Marina Liberati, MD, Giulia Benevolo, MD, Antonio Ledda, MD, Milena Gilestro, Monica Galli, MD, Francesca Patriarca, MD, Mariella Genuardi, MD, Nicola Giuliani, MD, Renato Zambello, MD, Adam Zdenek, Alessia La Fauci, MD, Paolo Corradini, Antonietta Pia Falcone, MD, Caterina Musolino, MD, Davide Rossi, MD, Ph.D., Patrizia Caraffa, MD, Pellegrino Musto, MD, Federica Cavallo, MD, Roman Hajek, MD, PhD, Mario Boccadoro, MD
Journal: Blood
Blood (2013) 122 (21): 536.
https://doi.org/10.1182/blood.V122.21.536.536
Published: 2013
Journal Articles

Reduced Dose-Intensity Subcutaneous Bortezomib Plus Prednisone (VP) Or Plus Cyclophosfamide (VCP) Or Plus Melphalan (VMP) For Newly Diagnosed Multiple Myeloma Patients Older Than 75 Years Of Age

Alessandra Larocca, MD, Federica Cavallo, MD, Valeria Magarotto, MD, Massimo Offidani, MD, Vincenzo Federico, MD, Vanessa Innao, MD, Antonietta Pia Falcone, MD, Alessandra Romano, MD, Tommaso Caravita, MD, Davide Rossi, MD, Giovanna Mansueto, MD, Roberto Mina, MD, Chiara Nozzoli, MD, Giulia Benevolo, MD, Tommasina Guglielmelli, MD, Anna Marina Liberati, MD, Daniele Derudas, MD, Stefania Oliva, Fortunato Morabito, MD, Angelo Michele Carella, MD, Silvia Gentili, MD, Elona Saraci, Maria Teresa Petrucci, MD, Pieter Sonneveld, MD, Ph.D, Mario Boccadoro, MD, Antonio Palumbo, MD
Journal: Blood
Blood (2013) 122 (21): 539.
https://doi.org/10.1182/blood.V122.21.539.539
Published: 2013
Journal Articles

Overall Survival Benefit for Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance with Bortezomib-Thalidomide (VMPT-VT) Versus Bortezomib-Melphalan-Prednisone (VMP) in Newly Diagnosed Multiple Myeloma Patients

Antonio Palumbo, MD, Sara Bringhen, Davide Rossi, MD, Maide Cavalli, MD, Roberto Ria, MD, Silvia Gentilini, MD, Francesca Patriarca, Chiara Nozzoli, MD, Anna Levi, MD, Tommasina Guglielmelli, MD, Giulia Benevolo, MD, Donatella Vincelli, MD, Luca Baldini, Fortunato Morabito, MD, Mariella Grasso, MD, Roberto Marasca, MD, Manuela Rizzo, MD, Chiara Pautasso, Pharm D, Antonietta Pia Falcone, MD, Daniela Gottardi, MD, Vittorio Montefusco, MD, Caterina Musolino, MD, Clotilde Cangialosi, MD, Giovanna Mansueto, MD, Anna Marina Liberati, MD, Valeria Magarotto, MD, Paola Omedè, PhD, Pellegrino Musto, MD, Maria Teresa Petrucci, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2012) 120 (21): 200.
https://doi.org/10.1182/blood.V120.21.200.200
Published: 2012
Journal Articles

Relapsed or Refractory Multiple Myeloma: Prospective Study with Bortezomib, Non-Pegylated Liposomal Doxorubicin and Dexamethason (PAD Regimen)

Antonietta Pia Falcone, MD, Grazia Sanpaolo, MD, Giovanni Rossi, MD, Carlo Bodenizza, MD, Angelo Michele Carella, MD, Matteo Dell' Olio, MD, Michele Mario Greco, MD, Antonio La Sala, MD, Saverio Mantuano, MD, Lorella Melillo, MD, Emanuela Merla, MD, Michele Nobile, MD, Potito R Scalzulli, M.D., Silvana Capalbo, MD, Nicola Cascavilla, MD
Journal: Blood
Blood (2012) 120 (21): 5032.
https://doi.org/10.1182/blood.V120.21.5032.5032
Published: 2012
Journal Articles

Second Primary Malignancies in Newly Diagnosed Multiple Myeloma Patients Treated with Lenalidomide: Analysis of Pooled Data in 2459 Patients

Antonio Palumbo, MD, Alessandra Larocca, MD, Sonja Zweegman, MD PhD, Giulia Lupparelli, Agostina Siniscalchi, MD, Pellegrino Musto, MD, Moshe Levin, MD, Henk Lokhorst, MD, PhD, Sara Grammatico, MD, Lucio Catalano, MD, Roberto Ria, MD, Anna Marina Liberati, MD, Francesca Patriarca, MD, Giulia Benevolo, MD, Antonietta Pia Falcone, MD, Bronno van der Holt, PhD, Sylvia Verelst, MSc, Davide Rossi, Claudia Crippa, MD, Sara Bringhen, MD, Roman Hajek, MD, Andrew Spencer, MD, Mario Boccadoro, MD, Pieter Sonneveld, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 996.
https://doi.org/10.1182/blood.V118.21.996.996
Published: 2011
Journal Articles

Melphalan/Prednisone/Lenalidomide (MPR) Versus High-Dose Melphalan and Autologous Transplantation (MEL200) in Newly Diagnosed Multiple Myeloma (MM) Patients <65 Years: Results of a Randomized Phase III Study

Antonio Palumbo, MD, Federica Cavallo, MD, Izhar Hardan, MD, Barbara Lupo, MD, Valter Redoglia, PhD, Moshe Levin, MD, MS, Paolo Corradini, MD, Sara Pezzatti, MD, Francesca Patriarca, MD, Michele Cavo, MD, Magda Marcatti, MD, Norbert Pescosta, MD, Antonietta Pia Falcone, MD, Roberto Ria, MD, Davide Rossi, Giulia Benevolo, MD, Clotilde Cangialosi, MD, Monica Galli, MD, Lucio Catalano, MD, Anna Baraldi, MD, Angelo Michele Carella, MD, Annamaria Cafro, MD, Agostina Siniscalchi, MD, Claudia Crippa, MD, Sara Grammatico, MD, Maide Cavalli, Tommaso Caravita Di Toritto, MD, Francesco Di Raimondo, MD, Arnon Nagler, Mario Boccadoro, MD
Journal: Blood
Blood (2011) 118 (21): 3069.
https://doi.org/10.1182/blood.V118.21.3069.3069
Published: 2011
Journal Articles

Long Term Response After Lenalidomide Treatment for Patients with Multiple Myeloma Relapsed After at Least Two Lines of Therapy.

Francesco Spina, MD, Vittorio Montefusco, MD, Claudia Crippa, MD, Barbara Oliviero, MD, Massimo Offidani, MD, Francesca Patriarca, MD, Daniela Petro', MD, Monica Galli, MD, Tommasina Guglielmelli, MD, Davide Rossi, MD, Antonietta Pia Falcone, MD, Marianna De Muro, MD, Paolo Corradini, MD
Journal: Blood
Blood (2009) 114 (22): 4946.
https://doi.org/10.1182/blood.V114.22.4946.4946
Published: 2009
Journal Articles

Sequential Approach with Bortezomib as Induction Before Autologous Transplantation, Followed by Lenalidomide as Consolidation-Maintenance in Untreated Multiple Myeloma Patients.

Francesca Gay, MD, Patrizia Falco, MD, Claudia Crippa, MD, Anna Marina Liberati, MD, Francesca Patriarca, MD, Clotilde Cangialosi, MD, Vincenzo Capparella, MD, Agostina Siniscalchi, MD, Manuela Rizzo, MD, Luca De Rosa, MD, Antonietta Pia Falcone, MD, Simona Caltagirone, PhD, Sara Bringhen, MD, Paolo Corradini, MD, Mario Boccadoro, MD, Antonio Palumbo, MD
Journal: Blood
Blood (2009) 114 (22): 3419.
https://doi.org/10.1182/blood.V114.22.3419.3419
Published: 2009
Journal Articles

A Prospective Randomized Phase I/II Study of Lenalidomide, Melphalan, Prednisone and Thalidomide (RMPT) for Relapsed/Refractory Multiple Myeloma Patients.

Federica Cavallo, MD, Alessandra Larocca, MD, Maria Teresa Petrucci, MD, Vincenzo Federico, MD, Antonietta Pia Falcone, MD, Grazia Sanpaolo, MD, Letizia Canepa, MD, Monica Crugnola, MD, Mario Boccadoro, MD, Antonio Palumbo, MD
Journal: Blood
Blood (2009) 114 (22): 2864.
https://doi.org/10.1182/blood.V114.22.2864.2864
Published: 2009
Journal Articles

Gemtuzumab Ozogamicin as Maintenance Therapy after Autologous Stem Cell Transplantation (ASCT) in Patients with Acute Myeloid Leukemia (AML).

Nicola Cascavilla, MD, Carlo Bodenizza, MD, Angelo Michele Carella, MD, Matteo Dell’Olio, MD, Antonietta Pia Falcone, MD, Michele Mario Greco, MD, Antonio La Sala, MD, Saverio Mantuano, MD, Lorella Melillo, MD, Emanuela Merla, MD, Michele Nobile, MD, Grazia Sanpaolo, MD, Potito Scalzulli, MD
Journal: Blood
Blood (2007) 110 (11): 4380.
https://doi.org/10.1182/blood.V110.11.4380.4380
Published: 2007